Cargando…
A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision
Neoadjuvant radio-chemotherapy followed by total mesorectal excision (TME) is the standard treatment option for stage II and III rectal cancer. However, for pT3N0 rectal cancer patients who receive upfront TME, the lack of an efficient method to predict their prognosis hampers postoperative treatmen...
Autores principales: | Xiao, Wei-Wei, Zhang, Lu-Ning, You, Kai-Yun, Huang, Rong, Yu, Xin, Ding, Pei-Rong, Gao, Yuan-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466410/ https://www.ncbi.nlm.nih.gov/pubmed/26078791 http://dx.doi.org/10.7150/jca.11727 |
Ejemplares similares
-
Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015) -
Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007) -
Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021) -
Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021) -
Pure transanal total mesorectal excision for rectal cancer: experience with 55 cases
por: Wang, Xiao-Ming, et al.
Publicado: (2019)